Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP10783.RADqIp7-EWlc-vncTqH4EZEDzC0YRxJBUdX3DPAve75TE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_curated type ECO_0000205 NP10783.RADqIp7-EWlc-vncTqH4EZEDzC0YRxJBUdX3DPAve75TE130_provenance.
- source_evidence_curated label "DisGeNET evidence - CURATED" NP10783.RADqIp7-EWlc-vncTqH4EZEDzC0YRxJBUdX3DPAve75TE130_provenance.
- source_evidence_curated comment "Gene-disease associations manually curated." NP10783.RADqIp7-EWlc-vncTqH4EZEDzC0YRxJBUdX3DPAve75TE130_provenance.
- NP10783.RADqIp7-EWlc-vncTqH4EZEDzC0YRxJBUdX3DPAve75TE130_assertion description "[Therefore, we concluded that CBR1 is a good molecular target for the development of anticancer drugs for HCC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP10783.RADqIp7-EWlc-vncTqH4EZEDzC0YRxJBUdX3DPAve75TE130_provenance.
- NP10783.RADqIp7-EWlc-vncTqH4EZEDzC0YRxJBUdX3DPAve75TE130_assertion evidence source_evidence_curated NP10783.RADqIp7-EWlc-vncTqH4EZEDzC0YRxJBUdX3DPAve75TE130_provenance.
- NP10783.RADqIp7-EWlc-vncTqH4EZEDzC0YRxJBUdX3DPAve75TE130_assertion SIO_000772 21056497 NP10783.RADqIp7-EWlc-vncTqH4EZEDzC0YRxJBUdX3DPAve75TE130_provenance.
- NP10783.RADqIp7-EWlc-vncTqH4EZEDzC0YRxJBUdX3DPAve75TE130_assertion wasDerivedFrom ctd_human-20130708 NP10783.RADqIp7-EWlc-vncTqH4EZEDzC0YRxJBUdX3DPAve75TE130_provenance.
- NP10783.RADqIp7-EWlc-vncTqH4EZEDzC0YRxJBUdX3DPAve75TE130_assertion wasGeneratedBy ECO_0000218 NP10783.RADqIp7-EWlc-vncTqH4EZEDzC0YRxJBUdX3DPAve75TE130_provenance.
- ctd_human-20130708 importedOn "2013-07-24" NP10783.RADqIp7-EWlc-vncTqH4EZEDzC0YRxJBUdX3DPAve75TE130_provenance.